The expression and clinical significance of sphingosine kinase 1 and vascular endothelial growth factor in endometrial carcinoma

HIGHLIGHTS

• who: Hong Yu and colleagues from the Department of Pathology, The Third People`s Hospital of Shenzhen, Shenzhen, Guangdong, China Department of Gynecology, Hunan Provincial People`s Hospital (The First-affiliated Hospital of Hunan Normal University) have published the research: The Expression and Clinical Significance of Sphingosine Kinase 1 and Vascular Endothelial Growth Factor in Endometrial Carcinoma, in the Journal: Emergency Medicine International of 21/09/2022
• what: The aim of this study is to explore the expression of sphingosine kinase 1 (SPHK1) and VEGF in patients with endometrial carcinoma and its clinical significance and . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.